Molecular Diagnostics: Technologies and Global Markets 2022 Report: Market Projected to Grow from $17.6 Billion in 2021 to $42.6 Billion in 2026

DUBLIN, 03 May 2022–(BUSINESS WIRE)–The “Molecular Diagnostics: Technologies and Global Markets” report has been added to’s offer.

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The purpose of all DNA-based diagnostic tests is similar, but different technologies can be used. The report analyzes each technology in detail, determines key players and current market status, and presents growth forecasts for the next five years. Scientific challenges and progress, including the latest trends, are highlighted. Government regulations, major collaborations, recent patents and factors influencing the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also being explored.

Key molecular diagnostic technologies and products are analyzed to determine the current and future market status, and growth is forecast from 2021 to 2026. An in-depth discussion on strategic alliances, industry structures, competitive dynamics, patents, and market drivers is also provided.

Report contains

  • 60 tables

  • An overview of the global molecular diagnostics market and technologies

  • Estimation of the market size and analyzes of global market trends, with data from 2019 to 2021 and projections of Compound Annual Growth Rates (CAGRs) to 2026

  • Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region

  • Information on food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of new therapeutic products and their approvals

  • Discussion of related issues, government regulations and insurance reimbursements, patient confidentiality and other legal ramifications

  • Identification of market factors, restraints and other forces affecting the global market and evaluation of current market trends, size and forecast

  • Market share analysis of the industry’s key companies and reporting of events such as mergers and acquisitions, joint ventures, collaborations or partnerships and other key market strategies

  • Company profiles of major players including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc

Medical device companies, both industrial giants and start-ups, invest significantly in research and development (R&D) to develop innovative diagnostic products that can manage a wide range of medical conditions, including obesity, sleep apnea, diabetes, chronic obstructive pulmonary disease (COPD), asthma and heart disease, as well as disability rehabilitation and the monitoring of progressive nervous system disorders, such as Parkinson’s disease.

The increasing prevalence of diseases requiring 24-hour monitoring is a major driver of the market and is expected to contribute significantly to the double-digit growth of the industry, especially given the increase in the global geriatric population. Advances in technology are also driving the adoption of many diagnostic products.

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Introduction to Genomic Diagnostics

  • Expression Profiling and Disease

  • Expression Profiling and Infectious Disease

  • DNA sequencing for genotyping and diagnosis

  • Clinical Pharmacology

  • Mutation detection and genotyping for specific genes

  • Identification of new disease genes

Chapter 4 Impact of the Covid-19 pandemic

Chapter 5 Market Dynamics

  • Market factors

  • High incidence of infectious diseases

  • Increasing incidence of chronic diseases

  • Increase of the research and development budget

  • Increasing health care spending

  • Limitations and Challenges

  • Strict regulatory framework

  • High R&D and marketing costs

  • Opportunities

  • Point-of-care testing that minimizes reliance on lab testing

  • Discovery of new biomarkers and advances in molecular techniques

Chapter 6 Market breakdown by technology

Chapter 7 Molecular diagnostics by application

  • Infectious Diseases

  • Market size and forecast

  • oncology

  • leukemia

  • Chronic Myeloid Leukemia

  • Genetic marker of chronic myeloid leukemia

  • Market size and forecast

  • Pre- and postnatal screening

  • Carrier screening

  • Prenatal Diagnostic Testing

  • amniocentesis

  • Chorionic Villus Sampling

  • Genetic Counseling

  • Pre-implantation diagnosis

  • Newborn screening

  • Market size and forecast

  • Identity and Paternity

  • Paternity Tests

  • Technology

  • accreditation

  • Legal problems

  • Veterinary Identity Tests

  • Market size and forecast

  • others

  • Market size and forecast

Chapter 8 Market Breakdown by Region

Chapter 9 Regulations and Finance

  • Overview

  • Europe

  • US

  • Japan

  • Insurance

  • Food and Drug Administration Guidelines

  • Internal standards for DNA diagnostics

  • Minimal information about a microarray

  • Experiment: Miame 2.0

  • Microarray Quality Control Project

  • Changes for Clinical Lab Improvement

  • Personalized medicines and accompanying diagnostics

  • FDA Guidance for In Vitro Companion Diagnostics

  • Definition and Use of an Accompanying IVD Diagnostic Device

  • Review and Approval of Accompanying IVD Diagnostic Devices and Therapeutic Products

  • New therapeutic products

  • Approval of a therapeutic product without an approved IoT Companion diagnostic device

  • General policy

  • FDA-approved companion diagnostics

  • Nucleic Acid Based Tests

  • Pharmacogenomics Research Network

Chapter 10 Patents

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

Named companies

  • Abbott

  • Agilent Technologies Inc.

  • Almac Group

  • Becton, Dickinson and Co.

  • Bio-Rad Laboratories Inc.

  • Biomerieux Sa

  • Cardinal Health

  • Danaher Corp.

  • Elitech Group

  • General Electric

  • Grifols (Novartis Molecular Diagnostics)

  • Hologic Inc.

  • Illumina Inc.

  • Countless genetics

  • Philips Healthcare

  • Qiagen NV

  • Quest Diagnostics

  • Roche Holding AG (F. Hoffmann-La Roche Ltd.)

  • Siemens Healthcare

  • Thermo Fisher Scientific Inc.

For more information on this report, please visit

Check out the source version at

Laura Wood, senior press manager
[email protected]

For EST business hours, call 1-917-300-0470
For USA/CAN Toll Free Call 1-800-526-8630
For GMT office hours, call +353-1-416-8900

Leave a Comment